OĞUZÜLGEN, İ. K. Et Al. 2023. Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma. Annual congress of the European-Respiratory-Society (ERS) , (Milan, Italy).

OĞUZÜLGEN, İ. K., Tugay, D., TOP, M., AYDIN, Ö., BAVBEK, S., DAMADOĞLU, E., ... Erkekol, F. O.(2023). Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma . Annual congress of the European-Respiratory-Society (ERS), Milan, Italy

OĞUZÜLGEN, İPEK Et Al. "Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma," Annual congress of the European-Respiratory-Society (ERS), Milan, Italy, 2023

OĞUZÜLGEN, İPEK K. Et Al. "Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma." Annual congress of the European-Respiratory-Society (ERS) , Milan, Italy, 2023

OĞUZÜLGEN, İ. K. Et Al. (2023) . "Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma." Annual congress of the European-Respiratory-Society (ERS) , Milan, Italy.

@conferencepaper{conferencepaper, author={İPEK KIVILCIM OĞUZÜLGEN Et Al. }, title={Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthma}, congress name={Annual congress of the European-Respiratory-Society (ERS)}, city={Milan}, country={Italy}, year={2023}}